View Article

Abstract

Dentin hypersensitivity is characterized by sharp pain triggered by external stimuli such as temperature changes, tactile contact, or chemicals interacting with exposed dentin. This occurs due to the exposure of dentinal tubules, which connect the dental pulp to the enamel or cementum, allowing stimuli to activate sensory nerve fibers. Pain perception involves nerve activation, inflammatory mediators, and sensitized nerve endings. Potassium nitrate and potassium oxalate are key agents in managing dentin hypersensitivity, providing pain relief and improving oral health. 3% Potassium Nitrate Mouth Rinse: Potassium nitrate desensitizes nerve endings by blocking pain signal transmission and inducing nerve fiber depolarization, reducing responsiveness to stimuli. It is effective, widely used, and available in over-the-counter products like toothpastes and mouth rinses for daily use. 1.4% Potassium Oxalate Mouth Rinse: Potassium oxalate reduces sensitivity by forming a precipitate with calcium ions in the dentinal tubules, blocking fluid movement and external stimuli transmission. This occlusion effectively minimizes hypersensitivity and is often applied professionally by dental practitioners, with at-home maintenance solutions. This study aims to evaluate and compare the clinical effectiveness of 3% potassium nitrate and 1.4% potassium oxalate mouth rinses in managing dentin hypersensitivity.

Keywords

potassium oxalate, potassium nitrate, sensitivity, visual analogue scale and mouthrinses

Introduction

DENTINE HYPERSENSITIVITY:

Dentin hypersensitivity is a condition characterized by acute discomfort or pain in response to various external stimuli, such as thermal changes, osmotic gradients, tactile stimulation, or chemical substances, which come into contact with exposed dentin surfaces. This phenomenon arises due to the exposure of dentinal tubules, which are microtubular structures that traverse the dentin layer and connect the dental pulp to the outer enamel or cementum.

The perception of pain associated with dentin hypersensitivity involves the activation of sensory nerve fibres within the pulp-dentin complex, as well as the release of inflammatory mediators and neurotransmitters that sensitize nerve endings.

Potassium oxalate and potassium nitrate mouth rinses are prominent therapeutic agents utilized in the management of dentin hypersensitivity, a condition marked by acute pain or discomfort triggered by stimuli such as temperature variations, sweetness, or acidic substances. This physiological response significantly impacts an individual's oral health and overall quality of life. The primary objective of these mouth rinses is to mitigate hypersensitivity by addressing the root causes and providing relief to affected individuals.

3% POTASSIUM NITRATE MOUTH RINSE:

Mechanism of Action: Potassium nitrate operates by desensitizing nerve endings in dental tissues, thereby impeding the transmission of pain signals. Additionally, it induces the depolarization of nerve fibres, diminishing their responsiveness to external stimuli.

Benefits: Renowned for its prompt efficacy, potassium nitrate is a preferred choice for over-the-counter oral care products, providing rapid relief from dental hypersensitivity. Application: Over-the-counter toothpaste, mouth rinses, and gels containing potassium nitrate are readily available for daily use as part of a regular oral hygiene routine.

1.4% POTASSIUM OXALATE MOUTH RINSE:

Mechanism of Action: Potassium oxalate functions through the formation of a precipitate with calcium ions present in the dentinal tubules. This complex impedes the tubules, diminishing the conveyance of external stimuli to the nerves.

Benefits: Utilization of potassium oxalate facilitates the occlusion of exposed dentinal tubules, effectively impeding the fluid movement within, which is a contributing factor to hypersensitivity. Application: Typically, dental practitioners administer potassium oxalate mouth rinses professionally, complemented by at-home solutions for ongoing management.

Thus the primary purpose of conducting this study is to evaluate and compare clinically the effectiveness of 3% potassium nitrate mouthwash and 1.4% potassium oxalate mouthwash rinses in dentinal hypersensitivity.

AIMS AND OBJECTIVE OF THE STUDY:

AIM:

To evaluate the efficacy of 3% potassium nitrate mouthwash v/s 1.4% potassium oxalate mouthwash in dentinal hypersensitivity

OBJECTIVES:

1. To assess the efficacy of 3% potassium nitrate mouthwash and  1.4% potassium oxalate mouthwash in dentinal hyper sensitivity.

2. To clinically compare and evaluate the reduction in dentinal hypersensitivity over a period of 1 month.

MATERIALS AND METHODS

SOURCE OF DATA

The proposed study was a double blinded, comparative and parallel group study - a total of 10 patients was selected from the outpatient Department of Periodontology and Oral Implantology, National Dental College and Hospital, Dera Bassi, Punjab, India. An ethical approval for the study was obtained from the Institutional Ethical Board Committee at National Dental College and Hospital, Dera Bassi, Punjab (Appendix A). Each patient was given a detailed verbal and written description of study (Appendix B).

METHOD OF COLLECTION OF DATA

A) ETHICAL APPROVAL: Before starting the study, ethical approval from the institutional review board of National Dental College, Dera Bassi was obtained for conducting the study, (Appendix A)

B) SELECTION OF PARTICIPANTS

INCLUSION CRITERIA:

1. Patients willing to sign on a written consent form (Appendix A).

2. Male and female patients aged between 18- 60 years.

3. Patients with good general and oral health, with a minimum of 2 natural premolars, canines or incisors with caries free facial or buccal surfaces.

4. Patients with cervical abrasion, erosion or gingival recession.

EXCLUSION CRITERIA:

1. Dental pathosis which cause pain similar to cervical dentinal hypersensitivity (Teeth with caries).

2. Pregnant or lactating women.

3. A recent history or presence of any acute or chronic infections.

4. Orthodontic appliances or restoration (crowns, cervical restorations, bridge work) that interfere with the evaluation or were a possible cause of pain.

5. Allergy to drugs or chemicals used in the study.

6. Patients who are physically or mentally challenged.

GROUPING & SAMPLING

The selected patients was randomly distributed into two study group (5 patients in each group).

Group 1 - 3% potassium nitrate mouthwash in hypersensitivity

Group 2 - 1.4% potassium oxalate mouthwash in hypersensitivity

METHODOLOGY

At the beginning of the study, 10 patients was randomly divided into two groups.

Group 1 - 3% potassium nitrate mouthwash in hypersensitivity

Group 2 - 1.4% potassium oxalate mouthwash in hypersensitivity

CLINICAL PROCEDURE

Patient reporting to the Department of Periodontology and Oral Implantology with a chief complaint of hypersensitivity in their tooth and on the basis of inclusion criteria, patients were selected and divided into two study groups (5 patients in each group). Patient’s pain perception was measured on the basis of Visual Analogue Scale (VAS) and Cold air (thermal / evaporative method) intensity score on the day of screening and then were instructed to brush for twice (morning & evening) a day in their usual manner with the provided standard fluoride toothpaste (Parodontax) for 1 week prior the assigned oral rinses. After one week of patients reporting (baseline), they were randomized into two treatment groups. Baseline values was taken on this day and oral mouthwashes was assigned for Group 1- 3% potassium nitrate mouthwash and for Group 2 - 1.4% potassium oxalate mouthwash, 10mL solution for 10 seconds no further rinsing with water was permitted after oral rinse use; patients were asked to refrain from eating or drinking for 30 minutes. Patients were instructed to continue the assigned study treatment twice daily (morning & evening) for the next 1 week. In each centre, sealed envelopes including the code for treatment group were prepared. For randomization, two sets of envelopes (N=5) one with 3% potassium nitrate and other one with 1.3% potassium oxalate were prepared. In each centre, randomized assistant was involved who was doing the randomization. This person was different from the examiner and also from the one who were performed with the treatment. This allowed  the balanced allocation of the mouthrinses. Allocation of the treatment group were not revealed to the clinical examiner or the statistician. All the clinical parameters were recorded on baseline, 14th day and 1 month.

CLINICAL PARAMETERS

The following clinical parameters were recorded at baseline, 14th day and 1 month in both the groups:

1. Tactile method- probe intensity score: The patient were asked to rate the perception of the sensitivity experienced during the scratch process as a score of 0 to 10 (where 0 = no pain and 10 = excruciating pain) based on a numerical rating visual analogue scale (NRS) described by Gillam et al.

2. Cold air (thermal / evaporative method) intensity score: Exactly 10 minutes after the scratch response were recorded, a 1-second application of cold air from a dental unit syringe (at 20°± 3°C at 60 to 65 psi) was directed perpendicularly to the exposed root surface after isolating the test tooth. The patient were asked again to rate the perception of sensitivity (where 0 = no pain and 10 = excruciating pain).

3.Subjective reporting of pain at baseline – overall sensitivity score: patients were asked to rate their perception to hot/cold food and drink, air, toothbrushing and to sweet and sour food by providing a score of 0 to 10 (where 0 = no pain and 10 = excruciating pain).

DATA COLLECTION

All clinical parameters such as Probe Intensity Score, Cold Air Intensity Score and Overall Sensitivity Score with the help of visual analogue scale were recorded at baseline, 14th day and 1 month.

STATISTICAL ANALYSIS

Section-I: Intra-group comparisons

Table 1: Comparison of probe intensity score at different time period (Tactile method)

Test applied: One-way analysis of variance

NS: Non-significant (p>0.05)

Table 2: Comparison of probe intensity score at different time period (Cold air)

Test applied: One-way analysis of variance

NS: Non-significant (p>0.05)

Table 3: Comparison of overall sensitivity score at different time period (Pain-overall sensitivity score)

Test applied: One-way analysis of variance

NS: Non-significant (p>0.05)

Section-II: Inter-group comparisons

Table 4: Comparison of probe intensity score at different time period (Tactle method)

Test used: un-paired independent t-test

S = Significant (p<0.05)

NS = Non-significant (p>0.05)

Table 5: Comparison of probe intensity score at different time period (Cold air)

Test used: un-paired independent t-test

NS = Non-significant (p>0.05)

Table 6: Comparison of overall sensitivity score at different time period (Pain-Overall sensetivity scorer)

Test used: un-paired independent t-test

NS = Non-significant (p>0.05)

DISCUSSION:

Dentin hypersensitivity (DH) is a significant and increasingly common dental concern that affects a large segment of the population. It is characterized by short, sharp pain arising from exposed dentin in response to stimuli such as thermal changes, tactile pressure, osmotic variations, or chemical exposure. This condition can significantly impact an individual’s oral health, daily activities, and overall quality of life.

The pathophysiology of DH involves the exposure of dentinal tubules due to enamel loss, gingival recession, or periodontal disease, which allows external stimuli to reach the nerve endings within the pulp-dentin complex. The resulting pain is mediated through the activation of sensory nerve fibers and the movement of fluid within the tubules, as described by the hydrodynamic theory.

Potassium oxalate and potassium nitrate are two widely studied agents for managing DH, both demonstrating an approximate 30% reduction in sensitivity according to current literature. Potassium nitrate works by depolarizing nerve fibers and reducing their ability to transmit pain signals. On the other hand, potassium oxalate functions by occluding dentinal tubules, which restricts fluid movement and thereby minimizes the stimulation of nerve endings.

In this study, both potassium nitrate and potassium oxalate were shown to significantly reduce hypersensitivity when used as directed. The intra-group analysis revealed a statistically significant reduction in pain scores, confirming the effectiveness of each agent in alleviating DH symptoms. However, the inter-group comparison did not yield statistically significant results. This lack of significance could be attributed to the study's relatively small sample size, which may have limited the ability to detect differences between the two groups. A larger sample size could provide greater statistical power and more definitive conclusions.

It is important to note that the effectiveness of potassium nitrate and potassium oxalate can depend on several factors, including the severity of hypersensitivity, individual oral health conditions, and the consistency of product use. Regular and directed application of these agents is critical for achieving sustained relief. Potassium nitrate is often incorporated into over-the-counter toothpastes and mouth rinses, making it easily accessible for daily use. Potassium oxalate, while effective, is more commonly applied in professional dental settings, with follow-up maintenance solutions prescribed for at-home care.

Although this study did not establish a clear superiority of one agent over the other, the findings reinforce the role of potassium nitrate and potassium oxalate in effectively managing DH. Both agents offer unique mechanisms of action and can be tailored to individual patient needs. For clinicians, incorporating these treatments into comprehensive oral care strategies can significantly improve patient comfort and quality of life.

Future studies with larger sample sizes, longer follow-up periods, and standardized protocols are recommended to further compare the efficacy of potassium nitrate and potassium oxalate. Additionally, exploring combination therapies or novel formulations may offer enhanced benefits in addressing dentin hypersensitivity. Overall, potassium nitrate and potassium oxalate remain valuable and reliable treatment options for individuals suffering from this common dental condition.

CONCLUSION:

The results of the present study would appear to suggest that while there was a general decrease in  dentinal sensitivity levels over the period of 1 month which was assessed through Tactile probe, Cold Air, Overall Sensitivity Scores. Potassium Nitrate mouthrinse and Potassium Oxalate mouthrinse used twice daily as an adjunct to toothbrushing provided statistically significant and clinically relevant reduction in and control of dentinal hypersensitivity. Within the limitations of the study the diverse treatment approach for dentinal hypersensitivity often yield conflicting results although the development of new materials and newer techniques which may be used at home and in office for the treatment of dentinal hypersensitivity has lead to the possibility of alleviating the symptoms in many clinical cases.

REFERENCES

  1. Lynch, MC, Perfekt, R, McGuire, JA, Milleman, J, Gallob, J, Amini, P & Milleman, K 2018, ‘Potassium oxalate mouthrinse reduces dentinal hypersensitivity: A randomized controlled clinical study’ , The Journal of the American Dental Association, vol. 149, no. 7, pp. 608-618.
  2. Dionysopoulos, D, Gerasimidou, O & Beltes, C 2023, ‘Dentin Hypersensitivity: Etiology, Diagnosis and Contemporary Therapeutic Approaches—A Review in Literature’, Applied Sciences, vol. 13, no. 21, p.11632.
  3. Cunha-Cruz, J, Stout, JR, Heaton, LJ, Wataha, JC & Northwest PRECEDENT 2011, ‘Dentin hypersensitivity and oxalates: a systematic review’ Journal of dental research, vol. 90, no. 3, pp.304-310.
  4. Milleman, KR, Milleman, JL, Young, S, Butler, A, Araga, M & Atassi, M, 2019 ‘A method development randomised clinical study investigating efficacy of an experimental oral rinse in providing long-term relief from dentinal hypersensitivity’ Journal of Dentistry, vol. 91, p.100008.
  5. Milleman, KR, Milleman, JL, Young, S, Butler, A, Araga, M & Atassi, M, 2019,  ‘A method development randomised clinical study investigating efficacy of an experimental oral rinse in providing long-term relief from dentinal hypersensitivity’ Journal of Dentistry, vol. 91, p.100008.
  6. Gillam1, DG, Bulman, JS, Jackson, RJ & Newman1, H, 1996, ‘Efficacy of a potassium nitrate mouthwash in alleviating cervical dentine sensitivity (CDS)’ Journal of clinical periodontology, vol. 23, no. 11, pp.993-997.
  7. Manohar, B, Pebbili, KK & Shukla, K, 2024, ‘Potassium oxalate-based mouth rinse for rapid relief in dentinal hypersensitivity’ Journal of Oral Research and Review, vol.16, no. 1, pp.72-79.

Reference

  1. Lynch, MC, Perfekt, R, McGuire, JA, Milleman, J, Gallob, J, Amini, P & Milleman, K 2018, ‘Potassium oxalate mouthrinse reduces dentinal hypersensitivity: A randomized controlled clinical study’ , The Journal of the American Dental Association, vol. 149, no. 7, pp. 608-618.
  2. Dionysopoulos, D, Gerasimidou, O & Beltes, C 2023, ‘Dentin Hypersensitivity: Etiology, Diagnosis and Contemporary Therapeutic Approaches—A Review in Literature’, Applied Sciences, vol. 13, no. 21, p.11632.
  3. Cunha-Cruz, J, Stout, JR, Heaton, LJ, Wataha, JC & Northwest PRECEDENT 2011, ‘Dentin hypersensitivity and oxalates: a systematic review’ Journal of dental research, vol. 90, no. 3, pp.304-310.
  4. Milleman, KR, Milleman, JL, Young, S, Butler, A, Araga, M & Atassi, M, 2019 ‘A method development randomised clinical study investigating efficacy of an experimental oral rinse in providing long-term relief from dentinal hypersensitivity’ Journal of Dentistry, vol. 91, p.100008.
  5. Milleman, KR, Milleman, JL, Young, S, Butler, A, Araga, M & Atassi, M, 2019,  ‘A method development randomised clinical study investigating efficacy of an experimental oral rinse in providing long-term relief from dentinal hypersensitivity’ Journal of Dentistry, vol. 91, p.100008.
  6. Gillam1, DG, Bulman, JS, Jackson, RJ & Newman1, H, 1996, ‘Efficacy of a potassium nitrate mouthwash in alleviating cervical dentine sensitivity (CDS)’ Journal of clinical periodontology, vol. 23, no. 11, pp.993-997.
  7. Manohar, B, Pebbili, KK & Shukla, K, 2024, ‘Potassium oxalate-based mouth rinse for rapid relief in dentinal hypersensitivity’ Journal of Oral Research and Review, vol.16, no. 1, pp.72-79.

Photo
Dr. Numrah Haque
Corresponding author

PG Student, Department Of Periodontology And Oral Implantology, National Dental College And Hospital, Dera Bassi, Punjab, India.

Photo
Dr. Rakshita Sharma
Co-author

PG Student, Department of Periodontology and Oral Implantology, National Dental College and Hospital, Dera Bassi, Punjab, India.

Photo
Dr. Gurpreet Kaur
Co-author

Professor And HOD, Department Of Periodontology And Oral Implantology, National Dental College And Hospital, Dera Bassi, Punjab, India.

Photo
Dr. Navneet Kaur
Co-author

Reader, Department Of Periodontology And Oral Implantology, National Dental College And Hospital, Dera Bassi, Punjab, India.

Photo
Dr. Tania Goutam
Co-author

Senior Lecturer, Department Of Periodontology And Oral Implantology, National Dental College And Hospital, Dera Bassi, Punjab, India.

Dr. Numrah Haque, Dr. Rakshita Sharma, Dr. Gurpreet Kaur, Dr. Navneet Kaur, Dr. Tania Goutam, Comparative Evaluation of The Efficacy of 3% Potassium Nitrate Mouthwash v/s 1.4% Potassium Oxalate Mouthwash Rinses in Dentinal Hypersensitivity, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 2604-2614. https://doi.org/10.5281/zenodo.20128036

More related articles
Thalidomide Pharmacological Actions of a Banned Dr...
Gunukula Alekhya, Dr. P. Kishore Kumar, ...
A Review on Formulation and Evaluation of Floating...
Dr D.Rama Brahma Reddy , D.Tejaswi, S. Vamsi, Ch. Naga sai manika...
Nanocrystals: For Solubility Enhancement of Hydrop...
Vaishnavi Shelke, Madhuri Narode, Pratiksha Pawar, ...
A Brief Review on Sustained Release Matrix Tablets...
Harshada Auti, Adinath Sangale, Dr. Megha Salve, ...
Anti-Inflammatory Activity Of Momordica Charantia ...
Jayshri Dangi , Arpit Shrivastava , ...
Related Articles
Role Of Computer Aided Drug Design In Modern Drug Discovery...
Kiran kumari, Muskan Thakur, Sahil Dhiman, Shubham Dhiman, ...
Advances In Gene Therapy for Fanconi Anemia Using Hematopoietic Stem Cells: Curr...
Subhashini.R, Tanuvarthini.S.B, Aishwarya.s, Hema.v, Priyadharshini.R, Sreelakshmi.S, ...
Nanovaccines: A Revolutionary Paradigm in Immunization...
Gurpreet Kaur , Ashita Pawaiya , Damandeep Kaur , Sumit Pasricha , Priyanka Rani , ...
Thalidomide Pharmacological Actions of a Banned Drug...
Gunukula Alekhya, Dr. P. Kishore Kumar, ...
More related articles
Thalidomide Pharmacological Actions of a Banned Drug...
Gunukula Alekhya, Dr. P. Kishore Kumar, ...
A Review on Formulation and Evaluation of Floating Tablet as Gastro Retentive Dr...
Dr D.Rama Brahma Reddy , D.Tejaswi, S. Vamsi, Ch. Naga sai manikanta, M. Chetan, B. Adarsh Babu, J. ...
Nanocrystals: For Solubility Enhancement of Hydrophobic Drug...
Vaishnavi Shelke, Madhuri Narode, Pratiksha Pawar, ...
Thalidomide Pharmacological Actions of a Banned Drug...
Gunukula Alekhya, Dr. P. Kishore Kumar, ...
A Review on Formulation and Evaluation of Floating Tablet as Gastro Retentive Dr...
Dr D.Rama Brahma Reddy , D.Tejaswi, S. Vamsi, Ch. Naga sai manikanta, M. Chetan, B. Adarsh Babu, J. ...
Nanocrystals: For Solubility Enhancement of Hydrophobic Drug...
Vaishnavi Shelke, Madhuri Narode, Pratiksha Pawar, ...